Angel Biotechnology Holdings plc, (AIM: ABH) the
BIopharmaceutical contract manufacturer, is pleased to announce
its financial results for the six month period ended 30 June
Angel Biotechnology Holdings plc, (AIM: ABH) the
biopharmaceutical contract manufacturer, is delighted to
announce that it has been awarded a Licence to manufacture
Angel Biotechnology Holdings plc, (AIM: ABH) the
biopharmaceutical contract manufacturer, is pleased to announce
an extension to its GMP contract with ReNeuron Group
Angel Biotechnology Holdings plc, (Angel Biotechnology or
the Company) (AIM: ABH) the biopharmaceutical contract
manufacturer, announces its maiden preliminary results for the